Skip to main content
Tessa NewsLink
Paste a health news link, or browse

Source study found

Story checked

Mounting Evidence Shows a Common Plastic Chemical Can Affect Human Ovaries : ScienceAlert (opens in a new tab)

sciencealert.com · 2026-10-10

Short answerEvidenceSource

Short answer

Mostly not supported

Mostly not supported.

One claim goes further than the study. 4 other points were not covered by the paper.

  • 1 supported
  • 1 overstated
  • 4 not covered

Checked against the study summary. The full text wasn't available, so some details couldn't be settled either way.

Share this check

Follow the evidence trail
1
2

NewsLink checks it

Mostly not supported

One claim overstates the study. One of six checks out. Four claims the study doesn't address.

  • 1 supported
  • 1 overstated
  • 4 not covered
Open claim evidence
3
Source paper

Source layer

The 2 papers the story cites

Source study separated from background citations.

The research anchor for the report.

Then inspect each claim

Evidence layer

Claim by claim

Each claim gets a verdict. Expand it to see the evidence directly below.

6 claims in this story

Showing all 6 claimsChoose a verdict to focus the list.

Claim 1 of 6OverstatedThe authors conclude that current evidence indicates phthalates disrupt human ovarian function at epidemiologically relevant concentrations and may explain reported links between phthalate exposure and polycystic ovaries.View evidenceHide evidence

As statedepidemiologically relevant concentrations

Why this verdict

The profile supports ex vivo and in vitro evidence that MEHP perturbed transcriptomic, protein, pathway, communication, and mitochondrial endpoints, including at an epidemiologically relevant exposure concentration in the experimental design. But the supplied profile does not establish broad disruption of human ovarian function in vivo, does not specify that the key effects occurred specifically at the epidemiologically relevant dose, and does not mention evidence connecting these findings to polycystic ovaries. Framing the evidence as indicating disruption of human ovarian function at epidemiologically relevant concentrations and as potentially explaining polycystic-ovary links goes beyond what the abstract-level profile supports.

1

Study evidence

MEHP exposure altered transcriptomes across all profiled ovarian cell types, with disrupted pathways related to actin cytoskeleton, cell adhesion, and oxidative phosphorylation (OXPHOS).

“Ovarian tissue explants from seven donors ... were exposed to two MEHP concentrations: an epidemiologically relevant 20.51 nM and a 1000-fold higher 20.51 μM.”
2

Study evidence

Protein-level analyses (immunostaining) across six human ovarian explant donors exposed to MEHP for six days confirmed altered tissue expression of EIF5A, MT-ND3, MT-ND4L, and VCL.

“After six days, single-cell RNA sequencing (one donor) and immunostainings (six donors) were used...”
Claim 2 of 6Not coveredThe study was conducted by a team from the Karolinska Institute and its affiliated hospital in Sweden.View evidenceHide evidence

Why this verdict

The supplied paper profile does not provide author affiliations or institutional details, so the Karolinska Institute/Swedish affiliated hospital claim cannot be verified from the abstract-level evidence supplied.

Claim 3 of 6Not coveredThe researchers used ovarian tissue samples from seven individuals and exposed them in the lab to MEHP at 20.51 nM or 20.51 × 1000 nM for six days, with a solvent control.View evidenceHide evidence

As stated20.51 nM or 20.51 × 1000 nM; six days; seven individuals

Why this verdict

The abstract-level profile supports seven donors, ex vivo ovarian explant exposure, two MEHP concentrations of 20.51 nM and 20.51 μM/1000-fold higher, and six days of exposure. However, the stated solvent control is not reported in the supplied abstract-level profile, so the full methodological claim is not verifiable at this depth.

1

Study evidence

MEHP exposure altered transcriptomes across all profiled ovarian cell types, with disrupted pathways related to actin cytoskeleton, cell adhesion, and oxidative phosphorylation (OXPHOS).

“Ovarian tissue explants from seven donors ... were exposed to two MEHP concentrations: an epidemiologically relevant 20.51 nM and a 1000-fold higher 20.51 μM.”
2

Study evidence

Protein-level analyses (immunostaining) across six human ovarian explant donors exposed to MEHP for six days confirmed altered tissue expression of EIF5A, MT-ND3, MT-ND4L, and VCL.

“After six days, single-cell RNA sequencing (one donor) and immunostainings (six donors) were used...”
Claim 4 of 6Not coveredAcross cell types, gene expression differed significantly between control and MEHP exposure groups, and the changes generally increased with dose.View evidenceHide evidence

As statedsignificantly different; dose-dependent pattern

Why this verdict

The profile supports that MEHP altered transcriptomes across all profiled ovarian cell types. But the abstract-level profile does not provide detailed statistical metrics, control-group wording, or dose-specific/dose-response results; it explicitly notes that dose-specific effects or dose-response details are not specified. The asserted significant differences and general dose-increase pattern therefore are not verifiable at abstract depth.

1

Study evidence

MEHP exposure altered transcriptomes across all profiled ovarian cell types, with disrupted pathways related to actin cytoskeleton, cell adhesion, and oxidative phosphorylation (OXPHOS).

“Ovarian tissue explants from seven donors ... were exposed to two MEHP concentrations: an epidemiologically relevant 20.51 nM and a 1000-fold higher 20.51 μM.”
Claim 5 of 6Not coveredThe article says glial cells in the ovary appeared particularly sensitive to MEHP exposure, and that MEHP also reduced cell-to-cell communication more at the higher dose.View evidenceHide evidence

As statedgreater effect at a higher dose

Why this verdict

The profile supports that glial cells were identified as particularly susceptible and that inferred cell–cell communication, especially glial–stromal communication, was reduced. However, the claim that communication was reduced more at the higher dose is dose-specific, and the supplied abstract-level profile does not report dose-specific communication results. That magnitude/dose claim is not verifiable at this depth.

1

Study evidence

MEHP exposure altered transcriptomes across all profiled ovarian cell types, with disrupted pathways related to actin cytoskeleton, cell adhesion, and oxidative phosphorylation (OXPHOS).

“Ovarian tissue explants from seven donors ... were exposed to two MEHP concentrations: an epidemiologically relevant 20.51 nM and a 1000-fold higher 20.51 μM.”
Claim 6 of 6SupportedNew research published in eBioMedicine adds to concerns about phthalates by mapping how MEHP exposure affects the cellular machinery of human ovarian tissue.View evidenceHide evidence

Why this verdict

The supplied abstract-level profile supports the core claim that the paper mapped cell type–specific MEHP responses in adult human ovarian tissue explants using single-cell methods, including transcriptional/pathway changes across ovarian cell types. The journal name itself is not independently evidenced in the supplied profile, but the scientific substance of the claim is supported.

1

Study evidence

MEHP exposure altered transcriptomes across all profiled ovarian cell types, with disrupted pathways related to actin cytoskeleton, cell adhesion, and oxidative phosphorylation (OXPHOS).

“Ovarian tissue explants from seven donors ... were exposed to two MEHP concentrations: an epidemiologically relevant 20.51 nM and a 1000-fold higher 20.51 μM.”
Then look for missing context

Context layer

What the story left out

Important study details the story did not include.

  • Single-cell RNA sequencing discovery data came from explant(s) of one donor, limiting robustness of cell type–resolved findings.

    The story mentions seven individuals and a small sample, but its caveats do not clearly state the more interpretation-changing limitation that the scRNA-seq discovery dataset underlying the cell type–resolved claims was from one donor.

    From Ex vivo human ovarian tissue explant exposure with scRNA-seq and validation assays

  • Protein-level validation across six donors confirmed altered EIF5A, MT-ND3, MT-ND4L, and VCL expression.

    The story’s summarized claims focus on scRNA-seq/gene-expression and glial sensitivity; it does not reflect the separate immunostaining/protein-validation component across six donors.

    From ex_vivo_immunostaining_validation

  • Primary ovarian cell mitochondrial stress assays indicated increased proton leakage after MEHP exposure.

    The story does not mention the functional mitochondrial-stress validation in primary ovarian cells.

    From in_vitro_primary_cells_mitochondrial_stress

  • Stem cell–derived Schwann cells were used as a glial validation model and reportedly mirrored scRNA-seq findings.

    The story discusses ovarian glial sensitivity but does not mention the separate Schwann-cell validation model.

    From in vitro

  • Important limitation: sample sizes were small across assays, including seven explant donors total, scRNA-seq from one donor, primary cells from three donors, and immunostaining across six donors.

    The story acknowledges seven donors as a small sample, but it omits the assay-specific small-sample structure, especially scRNA-seq from one donor and primary-cell assays from three donors.

    From Ex vivo human ovarian tissue explant exposure with scRNA-seq and validation assays; ex_vivo_immunostaining_validation; i

  • Important limitation: one exposure level was 1000-fold higher than the epidemiologically relevant concentration, and the abstract does not specify dose-specific effects or dose-response details.

    The story states the two concentrations but does not frame the 1000-fold higher exposure as a limitation, and some claims imply dose-response or higher-dose effects that the abstract-level profile does not substantiate.

    From Ex vivo human ovarian tissue explant exposure with scRNA-seq and validation assays

5 things the story did carry across
  • Central design: ex vivo adult human ovarian tissue explants from seven donors were exposed to MEHP at 20.51 nM and 20.51 μM for six days.
  • MEHP altered transcriptomes across ovarian cell types and disrupted pathways related to actin cytoskeleton, cell adhesion, and oxidative phosphorylation.
  • Glial/ovarian nervous-system cells were identified as particularly susceptible to MEHP exposure.
  • MEHP reduced inferred cell–cell communication, particularly glial–stromal interactions.
  • Important limitation: ex vivo explant culture and in vitro cell models may not capture in vivo ovarian physiology or systemic exposure conditions.
Then read the study layer

Study layer

Study at a glance

Scan the study first. Expand only the parts you want to inspect.

Pieces of work

4

Evidence read

study summary

Lead result

ex vivo human

1Lead resultex vivo humanMap cell type–specific transcriptional and pathway responses of adult human ovarian tissue explants to MEHP exposure at single-cell resolution, including effects on glial cells and cell–cell communication.Ex vivo human ovarian tissue explant exposure with scRNA-seq and validation assaysExpand

In plain English

Ex vivo adult human ovarian tissue explants were exposed to two concentrations of MEHP (20.51 nM and 20.51 μM) for six days. Single-cell RNA-sequencing on one donor and immunostainings across other donors, together with primary-cell and Schwann-cell validation experiments, were used to map cell type–specific transcriptional responses. MEHP exposure altered transcriptomes across ovarian cell types, disrupting pathways tied to actin cytoskeleton, cell adhesion, and oxidative phosphorylation, with glial (ovarian nervous system) cells identified as particularly susceptible and showing reduced inferred glial–stromal cell–cell communication. Protein-level assays and mitochondrial stress assays provided supporting evidence (altered EIF5A, MT-ND3, MT-ND4L, VCL expression; increased proton leakage in primary cells).

Key findings

  • MEHP exposure altered transcriptomes across all profiled ovarian cell types, with disrupted pathways related to actin cytoskeleton, cell adhesion, and oxidative phosphorylation (OXPHOS).
  • Glial (ovarian nervous system) cells were identified as particularly susceptible to MEHP, with inferred reductions in glial–stromal cell–cell communication.
“Ovarian tissue explants from seven donors ... were exposed to two MEHP concentrations: an epidemiologically relevant 20.51 nM and a 1000-fold higher 20.51 μM.”
What this piece can’t prove
  • Single-cell RNA-seq data were obtained from explant(s) of one donor (limiting robustness of cell type–resolved discovery).
  • Ex vivo explant culture may not fully capture in vivo ovarian physiology or systemic exposures.
  • Sample sizes for various assays are small (seven donors total for explants; scRNA-seq from one donor; primary cells from three donors; immunostainings across six donors), restricting generalizability.
  • One exposure level is 1000-fold higher than the epidemiologically relevant concentration; abstract does not specify dose-specific effects or dose–response details.
  • Abstract does not report detailed quantitative effect sizes, statistical metrics, or full methodological parameters (e.g., scRNA-seq platform, computational pipelines).
2ex vivo humanValidate key MEHP-associated molecular changes from the explant scRNA-seq using protein-level and tissue-level measurements across multiple donors.ex vivo immunostaining validationExpand

In plain English

Immunostaining and protein-level analyses in MEHP-exposed human ovarian explants (six donors, 6-day exposure) were used to validate scRNA-seq–identified molecular changes. Protein measurements confirmed altered tissue-level expression of EIF5A, MT-ND3, MT-ND4L, and VCL, linking transcriptomic findings to mitochondrial/OXPHOS and adhesion/cytoskeleton pathways.

Key findings

  • Protein-level analyses (immunostaining) across six human ovarian explant donors exposed to MEHP for six days confirmed altered tissue expression of EIF5A, MT-ND3, MT-ND4L, and VCL.
“After six days, single-cell RNA sequencing (one donor) and immunostainings (six donors) were used...”
What this piece can’t prove

3 further details could not be confirmed from the summary.

3in vitroFunctionally assess mitochondrial consequences of MEHP exposure in primary ovarian cells (stress assay) and compare/replicate key response patterns in a glial model (stem cell–derived Schwann cells).in vitro primary cells mitochondrial stressExpand

In plain English

Primary human ovarian cells (derived from three gender-affirming surgery donors) were used to functionally evaluate mitochondrial consequences of MEHP exposure using a mitochondrial stress assay; the assay indicated increased proton leakage after MEHP exposure. Responses in stem cell–derived Schwann cells replicated key response patterns reported from the explant scRNA-seq/ tissue analyses.

Key findings

  • MEHP exposure increased proton leakage in primary human ovarian cells as measured by a mitochondrial stress assay.
  • Stem cell–derived Schwann cells replicated key response patterns observed in the explant scRNA-seq and validation experiments.
“Primary ovarian cells derived from three gender-affirming surgery patients ... were used for validation.”
What this piece can’t prove
  • Abstract provides limited methodological detail for the primary-cell mitochondrial stress assay (no assay platform, no exposure concentrations/duration, no replicate numbers or statistical metrics).
  • Small donor number for primary-cell assays (three donors) as reported in abstract.
  • Unclear whether primary-cell exposure conditions match explant exposures (concentration/duration) from the tissue experiments.
  • Replication in stem cell–derived Schwann cells is described without specifics on which endpoints were measured or their quantitative agreement with tissue-level data.
4in vitroFunctionally assess mitochondrial consequences of MEHP exposure in primary ovarian cells (stress assay) and compare/replicate key response patterns in a glial model (stem cell–derived Schwann cells).Expand

In plain English

Stem cell–derived Schwann cells were used as an in vitro glial validation model and reported to recapitulate the transcriptomic response patterns observed in MEHP-exposed human ovarian explant scRNA-seq, including disruption of actin cytoskeleton, cell adhesion, and oxidative phosphorylation pathways.

Key findings

  • Stem cell–derived Schwann cells showed responses that 'mirrored the scRNA-seq findings' from MEHP-exposed ovarian explants, indicating replication of pathway-level transcriptomic changes.
“...and stem cell-derived Schwann cells were used for validation.”
What this piece can’t prove
  • The abstract provides only a brief statement that Schwann cell responses 'mirrored' scRNA-seq findings; it lacks methodological and quantitative details for the Schwann cell experiments (e.g., number of replicates, exposure conditions, measurement platforms).

2 further details could not be confirmed from the summary.

Finally, the search trail

Method layer

NewsLink found the paper. Tessa takes you deeper.

NewsLink checks the story. Tessa is where you inspect the paper, authors, evidence, and research context.

Papers considered

The selected paper, plus nearby candidates.

PubMed, Crossref, Europe PMC · 16 candidate papers

Candidate

SLUSH VS LIQUID NITROGEN VITRIFICATION OF HUMAN OVARIAN TISSUE PRESERVES GENE EXPRESSION AND IMPROVES POST WARMING IN VITRO CULTURE

2017 · Crossref

Source (opens in a new tab)
Candidate

Fig. 2. The box plots demonstrating the SLC34A2 gene expression level in different histological subtypes of epithelial ovarian cancer from GEO database (Gene Expression Omnibus; accession code GSE6008). The ordinate axis shows the relative gene expression levels, the abscissa axis shows normal ovarian tissue and histological subtypes of epithelial ovarian cancer: serous (СКЯ), endometrioid (ЭКЯ), mucinous (МКЯ) ovarian carcinoma

Crossref

Source (opens in a new tab)

And 10 more candidates considered.